Search - tctmd.com

Displaying 21 - 40 of 620

Sort: Relevancy | Date

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Conference News AHA 2017

Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery

Shelley Wood

November 14, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

Presentation AHA 2017

The POISE-2 PCI Substudy

Presenter: Michelle M. Graham

November 14, 2017

Presentation AHA 2017

Subgroup Analysis from the RE-DUAL PCI Trial

Presenter: Jonas Oldgren

November 14, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News AHA 2017

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

Todd Neale

November 12, 2017

Presentation Cardiovascular Interventions 2017

PCI for STEMI Patients With Multivessel Disease: Fix The Culprit or All Lesions?

Presenter: Cindy L. Grines

November 10, 2017

News Daily News

Transradial Access in Primary PCI on the Upswing in the US but Still Uneven

Caitlin E. Cox

November 10, 2017

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

Presentation Cardiovascular Interventions 2017

Precision PCI Takes The Mystery Out Of Angioplasty

Presenter: Richard Shlofmitz

November 09, 2017

News Daily News

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

L.A. McKeown

November 08, 2017

Presentation Cardiovascular Interventions 2017

Tips and Tricks for PCI Success

Presenter: Curtiss T. Stinis

November 08, 2017

Presentation Cardiovascular Interventions 2017

The Hybrid Approach to CTO PCI

Presenter: Bill Lombardi

November 08, 2017

News Conference News TCT 2017

CrossBoss First Shows Promise for Antegrade CTO PCI

TCT Daily Staff

November 07, 2017

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

Advertisement

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

The POISE-2 PCI Substudy

Subgroup Analysis from the RE-DUAL PCI Trial

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

PCI for STEMI Patients With Multivessel Disease: Fix The Culprit or All Lesions?

Transradial Access in Primary PCI on the Upswing in the US but Still Uneven

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Precision PCI Takes The Mystery Out Of Angioplasty

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

Tips and Tricks for PCI Success

The Hybrid Approach to CTO PCI

CrossBoss First Shows Promise for Antegrade CTO PCI

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content